TCM Biotech International Corp. (TPEX:4169)
Taiwan
· Delayed Price · Currency is TWD 56.30
+0.30 (0.54%)
Apr 2, 2025, 2:51 PM CST
TCM Biotech International Revenue
TCM Biotech International had revenue of 329.94M TWD in the half year ending June 30, 2024, a decrease of -11.53%. This brings the company's revenue in the last twelve months to 834.32M, down -6.75% year-over-year. In the year 2023, TCM Biotech International had annual revenue of 969.62M with 20.84% growth.
Revenue (ttm)
834.32M
Revenue Growth
-6.75%
P/S Ratio
3.92
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 969.62M | 167.20M | 20.84% |
| Dec 31, 2022 | 802.42M | 100.38M | 14.30% |
| Dec 31, 2021 | 702.05M | -35.03M | -4.75% |
| Dec 31, 2020 | 737.08M | 168.45M | 29.62% |
| Dec 31, 2019 | 568.63M | 28.40M | 5.26% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Oneness Biotech | 117.93M |
| Lumosa Therapeutics | 39.15M |
| Pegavision | 6.82B |
| Center Laboratories | 1.62B |